MDNA 213
Alternative Names: MDNA-213; MDNA19-MDNA213; MDNA19/MDNA213; MDNA213-MDNA19Latest Information Update: 28 Aug 2023
At a glance
- Originator Medicenna Therapeutics
- Class Antineoplastics; Immunoglobulin Fc fragments; Immunotherapies; Interleukins; Recombinant fusion proteins
- Mechanism of Action Interleukin 2 replacements; Natural killer cell stimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer